Logo
I

ImmuneBiotech AB

6 employees

ImmuneBiotech discovers and develops novel probiotics with therapeutic effects

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Nutraceutical
MS
Health Care
Therapeutics
Clostridium difficile infection CDI
Probiotics
Microbiome
IBS
Chronic Fatigue Syndrome (ME/CFS)
Tregs
Lactobacilli

Date founded

2013

Funding rounds raised

I

ImmuneBiotech AB raised undisclosed on January 1, 2019

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

FAQ